Scientists from Rice and Houston Methodist have developed a new way to reduce inflammation in the brain, a discovery that could help fight diseases such as Alzheimer’s and Parkinson’s.
Rice scientists have developed a new drug delivery platform that could make it easier for patients to take their medications and may even boost drug efficacy.
A study led by Xu Zhang, Marimikel Charrier and Caroline Ajo-Franklin demonstrates an innovative method for the real-time, on-site detection of arsenite and cadmium.
Computational biochemist Linna An will join Rice’s Department of Biosciences with support from a $2 million award from the Cancer Prevention and Research Institute of Texas.
Rice bioengineer Mario Escobar has won a Transformational Project Award from the American Heart Association to develop a new therapy for heart failure.
Impaired neuromusculoskeletal function due to conditions such as stroke, osteoarthritis, cerebral palsy, Parkinson’s disease, limb amputation, spinal cord injury, traumatic brain injury and cancer is a leading cause of disability.
Rice statistician Erzsébet Merényi is part of a team of researchers awarded $1 million by the Cancer Prevention and Research Institute of Texas to develop AI tools that can identify lethal forms of prostate cancer earlier and improve treatment selection.
A team of researchers at Rice has developed an innovative AI-enabled, low-cost device that will make flow cytometry ⎯ a technique used to analyze cells or particles in a fluid using a laser beam ⎯ affordable and accessible.
In a breakthrough that could transform bioelectronic sensing, an interdisciplinary team of researchers at Rice University has developed a new method to dramatically enhance the sensitivity of enzymatic and microbial fuel cells using organic electrochemical transistors (OECTs).
Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand with focused ultrasound can significantly reduce tumor size and burden in prostate cancer models, according to a new study published in Advanced Science by researchers at Rice and Vanderbilt.
The Rice lab of bioengineer Gang Bao and collaborators at Baylor College of Medicine have developed a new gene-editing strategy that dramatically boosts the effectiveness of gene therapies in the liver, a breakthrough that could lead to new treatments for about 700 genetic disorders in this vital organ as well as in other organs and tissues.